Mechanisms Underlying the Protective Effect of the Peroxiredoxin-6 Are Mediated via the Protection of Astrocytes during Ischemia/Reoxygenation
Abstract
:1. Introduction
2. Results
2.1. Prx-6 Protects Hippocampal Cells from Death during Ischemia by Suppressing Global [Ca2+]i Increase
2.2. A Change in the Redox-Status of Cells and Suppression of ROS Ans NO Production Contribute to the Protective Properties of Prx-6 in the Brain
2.3. Antiapoptotic Action of Prx-6 in Ischemia/Reoxygenation
2.4. The Impact of Prx-6 on Signaling Pathways, Glutamate Receptors and Inflammatory State of Brain Cells
2.5. Effect of Prx-6 on OGD/R-Induced Gene Expression
3. Discussion
4. Materials and Methods
4.1. Preparation of Mixed Hippocampal Neuroglial Cell Cultures
4.2. Immunocytochemical Method
4.3. Fluorescent Ca2+ Measurements
4.4. Fluorescent ROS Measurements
4.5. Fluorescent NO and [Ca 2+]i Measurements
4.6. The Technique for Simulation of Ischemia-Like Conditions
4.7. Assessment of Cell Viability and Apoptosis
4.8. Extraction of RNA
4.9. Real-Time Polymerase Chain Reaction (RT-qPCR)
4.10. Statistical Analysis
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Kalogeris, T.; Baines, C.P.; Krenz, M.; Korthuis, R.J. Cell biology of ischemia/reperfusion injury. Int. Rev. Cell Mol. Biol. 2012, 298, 229–317. [Google Scholar]
- Granger, D.N.; Kvietys, P.R. Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol. 2015, 6, 524–551. [Google Scholar] [CrossRef] [Green Version]
- Angelova, P.R.; Abramov, A.Y. Role of mitochondrial ROS in the brain: From physiology to neurodegeneration. FEBS Lett. 2018, 592, 692–702. [Google Scholar] [CrossRef]
- Turovsky, E.A.; Zinchenko, V.P.; Gaidin, S.G.; Turovskaya, M.V. Calcium-binding proteins protect GABAergic neurons of the hippocampus from hypoxia and ischemia in vitro. Biochemistry 2018, 12, 74–84. [Google Scholar] [CrossRef]
- Brunelle, J.K.; Bell, E.L.; Quesada, N.M.; Vercauteren, K.; Tiranti, V.; Zeviani, M.; Scarpulla, R.C.; Chandel, N.S. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 2005, 1, 409–414. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gelderblom, M.; Leypoldt, F.; Steinbach, K.; Behrens, D.; Choe, C.U.; Siler, D.A.; Arumugam, T.V.; Orthey, E.; Gerloff, C.; Tolosa, E.; et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40, 1849–1857. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Turovskaya, M.V.; Turovsky, E.A.; Kononov, A.V.; Zinchenko, V.P. Short-term hypoxia induces a selective death of GABAergic neurons. Biochemistry 2014, 8, 125–135. [Google Scholar] [CrossRef]
- Turovskaya, M.V.; Gaidin, S.G.; Vedunova, M.V.; Babaev, A.A.; Turovsky, E.A. BDNF overexpression enhances the preconditioning effect of brief episodes of hypoxia, promoting survival of GABAergic neurons. Neurosci. Bull. 2020, 36, 733–760. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bruick, R.K. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. USA 2000, 97, 9082–9087. [Google Scholar] [CrossRef] [Green Version]
- Guo, K.; Searfoss, G.; Krolikowski, D.; Pagnoni, M.; Franks, C.; Clark, K.; Yu, K.T.; Jaye, M.; Ivashchenko, Y. Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ. 2001, 8, 367–376. [Google Scholar] [CrossRef] [Green Version]
- Maritim, A.C.; Sanders, R.A.; Watkins, J.B. Diabetes, oxidative stress, and antioxidants: A review. J. Biochem. Mol. Toxicol. 2003, 17, 24–38. [Google Scholar] [CrossRef]
- Sharapov, M.G.; Ravin, V.K.; Novoselov, V.I. Peroxiredoxins as multifunctional enzymes. Mol. Biol. 2014, 48, 600–628. [Google Scholar] [CrossRef]
- Chae, H.Z.; Oubrahim, H.; Park, J.W.; Rhee, S.G.; Chock, P.B. Protein glutathionylation in the regulation of peroxiredoxins: A family of thiol-specific peroxidases that function as antioxidants, molecular chaperones, and signal modulators. Antioxid. Redox Signal. 2012, 16, 506–523. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hanschmann, E.M.; Godoy, J.R.; Berndt, C.; Hudemann, C.; Lillig, C.H. Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: From cofactors to antioxidants to redox signaling. Antioxid. Redox Signal. 2013, 19, 1539–1605. [Google Scholar] [CrossRef] [PubMed]
- Kim, S.H.; Fountoulakis, M.; Cairns, N.; Lubec, G. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer’s disease and Down syndrome. J. Neural. Transm. Suppl. 2001, 61, 223–235. [Google Scholar]
- Ma, S.; Zhang, X.; Zheng, L.; Li, Z.; Zhao, X.; Lai, W.; Shen, H.; Lv, J.; Yang, G.; Wang, Q.; et al. Peroxiredoxin 6 is a crucial factor in the initial step of mitochondrial clearance and is upstream of the PINK1-parkin pathway. Antioxid. Redox Signal. 2016, 24, 486–501. [Google Scholar] [CrossRef] [PubMed]
- Eismann, T.; Huber, N.; Shin, T.; Kuboki, S.; Galloway, E.; Wyder, M.; Edwards, M.J.; Greis, K.D.; Shertzer, H.G.; Fisher, A.B.; et al. Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296, 266–274. [Google Scholar] [CrossRef] [Green Version]
- Sorokina, E.M.; Feinstein, S.I.; Zhou, S.; Fisher, A.B. Intracellular targeting of peroxiredoxin 6 to lysosomal organelles requires MAPK activity and binding to 14-3-3epsilon. Am. J. Physiol. Cell Physiol. 2011, 300, 1430–1441. [Google Scholar] [CrossRef] [Green Version]
- Turovsky, E.A.; Turovskaya, M.V.; Gaidin, S.G.; Zinchenko, V.P. Cytokine IL-10, activators of PI3-kinase, agonists of α-2 adrenoreceptor and antioxidants prevent ischemia-induced cell death in rat hippocampal cultures. Arch. Biochem. Biophys. 2017, 615, 35–43. [Google Scholar] [CrossRef]
- Gaidin, S.G.; Turovskaya, M.V.; Mal’tseva, V.N.; Zinchenko, V.P.; Blinova, E.V.; Turovsky, E.A. A complex neuroprotective effect of alpha-2-adrenergic receptor agonists in a model of cerebral ischemia–reoxygenation in vitro. Biochemistry 2019, 13, 319–333. [Google Scholar] [CrossRef]
- Abramov, A.Y.; Scorziello, A.; Duchen, M.R. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J. Neurosci. 2007, 27, 1129–1138. [Google Scholar] [CrossRef] [PubMed]
- Turovskaya, M.V.; Gaidin, S.G.; Mal’tseva, V.N.; Zinchenko, V.P.; Turovsky, E.A. Taxifolin protects neurons against ischemic injury in vitro via the activation of antioxidant systems and signal transduction pathways of GABAergic neurons. Mol. Cell. Neurosci. 2019, 96, 10–24. [Google Scholar] [CrossRef]
- Angelova, P.R.; Kasymov, V.; Christie, I.; Turovsky, E.; Sheikhbahaei, S.; Marina, N.; Korsak, A.; Zwicker, J.; Teschemacher, A.G.; Funk, G.D.; et al. Functional oxygen sensitivity of astrocytes. J. Neurosci. 2015, 35, 10460–10473. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sharapov, M.G.; Novoselov, V.I.; Gudkov, S.V. Radioprotective role of peroxiredoxin 6. Antioxidants 2019, 8, 15. [Google Scholar] [CrossRef] [Green Version]
- Coimbra-Costa, D.; Alva, N.; Duran, M.; Carbonell, T.; Rama, R. Oxidative stress and apoptosis after acute respiratory hypoxia and reoxygenation in rat brain. Redox Biol. 2017, 12, 216–225. [Google Scholar] [CrossRef] [PubMed]
- Gaidin, S.G.; Turovskaya, M.V.; Gavrish, M.S.; Babaev, A.A.; Mal’tseva, V.N.; Blinova, E.V.; Turovsky, E.A. The selective BDNF overexpression in neurons protects neuroglial networks against OGD and glutamate-induced excitotoxicity. Int. J. Neurosci. 2020, 130, 363–383. [Google Scholar] [CrossRef]
- Hossain, M.A.; De Souza, A.I.; Bagul, A.; MacPhee, I.A.; Kessaris, N.; Morsy, M.A. HSP70, Peroxiredoxin-3 and -6 are upregulated during renal warm ischaemia in a donation after circulatory death model. J. Proteom. 2014, 108, 133–145. [Google Scholar] [CrossRef]
- Perkins, A.; Poole, L.B.; Karplus, P.A. Tuning of peroxiredoxin catalysis for various physiological roles. Biochemistry 2014, 53, 7693–7705. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fisher, A.B.; Vasquez-Medina, J.P.; Dodia, C.; Sorokina, E.M.; Tao, J.-Q.; Feinstein, S.I. Peroxiredoxin 6 phospholipid hydroperoxidase activity in the repair of peroxidized cell membranes. Redox Biol. 2018, 14, 41–46. [Google Scholar] [CrossRef] [PubMed]
- Jin, M.H.; Lee, Y.H.; Kim, J.M.; Sun, H.N.; Moon, E.Y.; Shong, M.H.; Kim, S.U.; Lee, S.H.; Lee, T.H.; Yu, D.Y.; et al. Characterization of neural cell types expressing peroxiredoxins in mouse brain. Neurosci. Lett. 2005, 381, 252–257. [Google Scholar] [CrossRef]
- Sarafian, T.A.; Verity, M.A.; Vinters, H.V.; Shih, C.C.; Shi, L.; Ji, X.D.; Dong, L.; Shau, H. Differential expression of peroxiredoxin subtypes in human brain cell types. J. Neurosci. Res. 1999, 56, 206–212. [Google Scholar] [CrossRef]
- Kuang, X.; Wang, L.F.; Yu, L.; Li, Y.J.; Wang, Y.N.; He, Q.; Chen, C.; Du, J.R. Ligustilide ameliorates neuroinflammation and brain injury in focal cerebral ischemia/reperfusion rats: Involvement of inhibition of TLR4/peroxiredoxin 6 signaling. Free Radic. Biol. Med. 2014, 71, 165–175. [Google Scholar] [CrossRef] [PubMed]
- Power, J.H.; Asad, S.; Chataway, T.K.; Chegini, F.; Manavis, J.; Temlett, J.A.; Jensen, P.H.; Blumbergs, P.C.; Gai, W.P. Peroxiredoxin 6 in human brain: Molecular forms, cellular distribution and association with Alzheimer’s disease pathology. Acta Neuropathol. 2008, 115, 611–622. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Power, J.H.; Shannon, J.M.; Blumbergs, P.C.; Gai, W.P. Nonselenium glutathione peroxidase in human brain: Elevated levels in Parkinson’s disease and dementia with lewy bodies. Am. J. Pathol. 2002, 161, 885–894. [Google Scholar] [CrossRef]
- Lei, X.G.; Zhu, J.H.; Cheng, W.H.; Bao, Y.; Ho, Y.S.; Reddi, A.R.; Holmgren, A.; Arnér, E.S. Paradoxical roles of antioxidant enzymes: Basic mechanisms and health implications. Physiol. Rev. 2016, 96, 307–364. [Google Scholar] [CrossRef] [Green Version]
- Nair, D.; Ramesh, V.; Li, R.C.; Schally, A.V.; Gozal, D. Growth hormone releasing hormone (GHRH) signaling modulates intermittent hypoxia-induced oxidative stress and cognitive deficits in mouse. J. Neurochem. 2013, 127, 531–540. [Google Scholar] [CrossRef] [Green Version]
- Park, H.J.; Lee, D.G.; Seong, J.B.; Lee, H.S.; Kwon, O.S.; Kang, B.S.; Park, J.W.; Lee, S.R.; Lee, D.S. Peroxiredoxin I maintains luteal function by regulating unfolded protein response. Reprod. Biol. Endocrinol. 2018, 16, 79. [Google Scholar] [CrossRef]
- Nordzieke, D.E.; Medraño-Fernandez, I. The plasma membrane: A platform for intra- and intercellular redox signaling. Antioxidants 2018, 20, 168. [Google Scholar] [CrossRef] [Green Version]
- Schiavone, S.; Sorce, S.; Dubois-Dauphin, M.; Jaquet, V.; Colaianna, M.; Zotti, M.; Cuomo, V.; Trabace, L.; Krause, K.H. Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats. Biol. Psychiatry 2009, 66, 384–392. [Google Scholar] [CrossRef]
- Vaarmann, A.; Gandhi, S.; Abramov, A.Y. Dopamine induces Ca2+ signaling in astrocytes through reactive oxygen species generated by monoamine oxidase. J. Biol. Chem. 2010, 285, 25018–25023. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Levitt, P.; Pintar, J.E.; Breakefield, X.O. Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Proc. Natl. Acad. Sci. USA 1982, 79, 6385–6389. [Google Scholar] [CrossRef] [Green Version]
- Westlund, K.N.; Denney, R.M.; Kochersperger, L.M.; Rose, R.M.; Abell, C.W. Distinct monoamine oxidase A and B populations in primate brain. Science 1985, 230, 181–183. [Google Scholar] [CrossRef] [PubMed]
- Youdim, M.B.; Bakhle, Y.S. Monoamine oxidase: Isoforms and inhibitors in Parkinson’s disease and depressive illness. Br. J. Pharmacol. 2006, 147, 287–296. [Google Scholar] [CrossRef] [Green Version]
- Min, Y.; Wi, S.M.; Shin, D.; Chun, E.; Lee, K.-Y. Peroxiredoxin-6 negatively regulates bactericidal activity and NF-kB activity by interrupting TRAF6-ECSIT complex. Front. Cell. Infect. Microbiol. 2017, 7, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Barañano, D.E.; Snyder, S.H. Neural roles for heme oxygenase: Contrasts to nitric oxide synthase. Proc. Natl. Acad. Sci. USA 2001, 98, 10996–11002. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nitti, M.; Piras, S.; Brondolo, L.; Marinari, U.M.; Pronzato, M.A.; Furfaro, A.L. Heme Oxygenase 1 in the nervous system: Does it favor neuronal cell survival or induce neurodegeneration? Int. J. Mol. Sci. 2018, 19, 2260. [Google Scholar] [CrossRef] [Green Version]
- Kim, H.S.; Manevich, Y.; Feinstein, S.I.; Pak, J.H.; Ho, Y.S.; Fisher, A.B. Induction of 1-cys peroxiredoxin expression by oxidative stress in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285, 363–369. [Google Scholar] [CrossRef] [Green Version]
- Nurmi, A.; Lindsberg, P.J.; Koistinaho, M.; Zhang, W.; Juettler, E.; Karjalainen-Lindsberg, M.L.; Weih, F.; Frank, N.; Schwaninger, M.; Koistinaho, J. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 2004, 35, 987–991. [Google Scholar] [CrossRef] [Green Version]
- Pak, J.H.; Son, W.C.; Seo, S.B.; Hong, S.J.; Sohn, W.M.; Na, B.K.; Kim, T.S. Peroxiredoxin 6 expression is inversely correlated with nuclear factor-κB activation during Clonorchis sinensis infestation. Free Radic. Biol. Med. 2016, 99, 273–285. [Google Scholar] [CrossRef]
- Staal, F.J.; Roederer, M.; Herzenberg, L.A. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 1990, 87, 9943–9947. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Palayoor, S.T.; Youmell, M.Y.; Calderwood, S.K.; Coleman, C.N.; Price, B.D. Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen. Oncogene 1999, 18, 7389–7394. [Google Scholar] [CrossRef]
- Goncharov, R.G.; Rogov, K.A.; Temnov, A.A.; Novoselov, V.I.; Sharapov, M.G. Protective role of exogenous recombinant peroxiredoxin 6 under ischemia-reperfusion injury of kidney. Cell Tissue Res. 2019, 378, 319–332. [Google Scholar] [CrossRef]
- Leak, R.K.; Zhang, L.; Luo, Y. Peroxiredoxin 2 battles poly(ADP-ribose) polymerase 1- and p53-dependent prodeath pathways after ischemic injury. Stroke 2013, 44, 1124–1134. [Google Scholar] [CrossRef] [Green Version]
- Turovsky, E.A.; Zinchenko, V.P.; Kaimachnikov, N.P. Attenuation of calmodulin regulation evokes Ca2+oscillations: Evidence for the involvement of intracellular arachidonate-activated channels and connexons. Mol. Cell. Biochem. 2019, 456, 191–204. [Google Scholar] [CrossRef]
- Kim, S.Y.; Jo, H.-Y.; Kim, M.H.; Cha, Y.-Y.; Choi, S.W.; Shim, J.-H.; Kim, T.J.; Lee, K.-Y. H2O2-dependent hyperoxidation of peroxiredoxin 6 (Prdx6) plays a role in cellular toxicity via up-regulation of iPLA2 activity. J. Biol. Chem. 2008, 283, 33563–33568. [Google Scholar] [CrossRef] [Green Version]
- Sánchez-Alegría, K.; Flores-León, M.; Avila-Muñoz, E.; Rodríguez-Corona, N.; Arias, C. PI3K signaling in neurons. Int. J. Mol. Sci. 2018, 19, 3725. [Google Scholar] [CrossRef] [Green Version]
- Yamaguchi, A.; Tamatani, M.; Matsuzaki, H.; Namikawa, K.; Kiyama, H.; Vitek, M.P.; Mitsuda, N.; Tohyama, M. Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J. Biol. Chem. 2001, 276, 5256–5264. [Google Scholar] [CrossRef] [Green Version]
- Dhanasekaran, D.N.; Reddy, E.P. JNK signaling in apoptosis. Oncogene 2008, 27, 6245–6251. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Park, S. Polyphenol compound as a transcription factor inhibitor. Nutrients 2015, 7, 5445. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Turovskaya, M.V.; Zinchenko, V.P.; Babaev, A.A.; Epifanova, E.A.; Tarabykin, V.S.; Turovsky, E.A. Mutation in the Sip1 transcription factor leads to a disturbance of the preconditioning of AMPA receptors by episodes of hypoxia in neurons of the cerebral cortex due to changes in their activity and subunit composition. The protective effects of interleukin-10. Arch. Biochem. Biophys. 2018, 654, 126–135. [Google Scholar] [PubMed]
- Molina, C.A.; Alvarez-Sabín, J. Recanalization and reperfusion therapies for acute ischemic stroke. Cerebrovasc. Dis. 2009, 2, S162–S167. [Google Scholar] [CrossRef]
- Shah, I.M.; Macrae, I.M.; Di Napoli, M. Neuroin flammation and neuroprotective strategies in acute ischaemic stroke—From bench to bedside. Curr. Mol. Med. 2009, 9, 336–354. [Google Scholar] [CrossRef] [PubMed]
- O’Collins, V.E.; Macleod, M.R.; Donnan, G.A.; Horky, L.L.; Van der Worp, B.H.; Howells, D.W. 1.026 experimental treatments in acute stroke. Ann. Neurol. 2006, 59, 467–477. [Google Scholar] [CrossRef] [PubMed]
- Maksimenko, A.V.; Vavaev, A.V. Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: The next stage of pharmacological counterwork to the oxidative stress. Heart Int. 2012, 7, 7. [Google Scholar] [CrossRef]
- Ouyang, Y.-B.; Xu, L.; Yue, S.; Liu, S.; Giffard, R.G. Neuroprotection by astrocytes in brain ischemia. Neurosci. Lett. 2014, 565, 53–58. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zuany-Amorim, C.; Hastewell, J.; Walker, C. Toll-like receptors as potential therapeutic targets for multiple diseases. Nat. Rev. Drug Discov. 2002, 1, 797–807. [Google Scholar] [CrossRef]
- Brea, D.; Blanco, M.; Ramos-Cabrer, P.; Moldes, O.; Arias, S.; Pérez-Mato, M.; Leira, R.; Sobrino, T.; Castillo, J. Toll-like receptors 2 and 4 in ischemic stroke: Outcome and therapeutic values. J. Cereb. Blood Flow Metab. 2011, 31, 1424–1431. [Google Scholar] [CrossRef] [Green Version]
- Eltzschig, H.K.; Eckle, T. Ischemia and reperfusion—From mechanism to translation. Nat. Med. 2011, 17, 1391–1401. [Google Scholar] [CrossRef] [Green Version]
- Shichita, T.; Hasegawa, E.; Kimura, A.; Morita, R.; Sakaguchi, R.; Takada, I.; Sekiya, T.; Ooboshi, H.; Kitazono, T.; Yanagawa, T.; et al. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat. Med. 2012, 18, 911–917. [Google Scholar] [CrossRef]
- Zinchenko, V.P.; Turovskaya, M.V.; Teplov, I.Y.; Berezhnov, A.V.; Turovsky, E.A. The role of parvalbumin-containing interneurons in the regulation of spontaneous synchronous activity of brain neurons in culture. Biophysics 2016, 61, 85–93. [Google Scholar] [CrossRef]
- Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Turovsky, E.A.; Varlamova, E.G.; Plotnikov, E.Y. Mechanisms Underlying the Protective Effect of the Peroxiredoxin-6 Are Mediated via the Protection of Astrocytes during Ischemia/Reoxygenation. Int. J. Mol. Sci. 2021, 22, 8805. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22168805
Turovsky EA, Varlamova EG, Plotnikov EY. Mechanisms Underlying the Protective Effect of the Peroxiredoxin-6 Are Mediated via the Protection of Astrocytes during Ischemia/Reoxygenation. International Journal of Molecular Sciences. 2021; 22(16):8805. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22168805
Chicago/Turabian StyleTurovsky, Egor A., Elena G. Varlamova, and Egor Y. Plotnikov. 2021. "Mechanisms Underlying the Protective Effect of the Peroxiredoxin-6 Are Mediated via the Protection of Astrocytes during Ischemia/Reoxygenation" International Journal of Molecular Sciences 22, no. 16: 8805. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22168805